Seeking Alpha


Send Message
View as an RSS Feed
View kmin525's Comments BY TICKER:
Latest  |  Highest rated
  • Parsing Talk Surrounding Pfizer's Mystery Drug At Antares [View article]
    Interesting..but definately NOT OTC Lipitor.
    FDA will never ever approve it. Too much side-effects and interactions with other RX. (ie. muscle spasm/muscle breakdown, interactions with warfarin, interactions with multiple antibiotics, etc)

    It is def. not lipitor that is on disucssion..
    1) Lipitor NO WAY

    Second point: about male birth control. There are some birth control under development currently and also there are some birth control for male (via injection to scrotum *effects lasts 6 months* i belive...) But would the market be big for that? who in the world wanna get shot at their balls..

    Just my 2cents..
    Jul 12 07:57 PM | Likes Like |Link to Comment
  • 4 Big Pharma Stocks To Buy Now, 2 To Watch [View article]
    FYI: patent for singular has already expired in some countries already. In canada generic singular (ie. TEVA) has been available for quite awhile...
    Jul 11 07:49 PM | Likes Like |Link to Comment
  • Why Getting Under The Skin May Enhance Antares' Near-Term Revenue Stream [View article]
    Yes.. I do realize that "intradermal" patent could be very big THAT is BIG IF. It will depend on how many drugs will utilize it. I can't name or number how many drugs could be potential candidate for "intradermal" injection, but i can tell you that currently there aren't many as of yet as a pharmacist who has been working with various drug companies. The reason is like i have mentioned before, currently majority of SC/IM injections cannot be given intradermal due to pharmacokinetics of the drug. However, I am not doubting its potential.

    I would get more excited if they could get SANDOZ on board as they are another big player in drug market just like Teva. As matter fact SANDOZ produce more injectables than Teva alone.

    If they can develop it so that INSULINS can be administered "intradermal" than it would be blockbuster for sure. However, I don't think it will be possible or maybe perhaps in the future.

    Currently, I still believe ATRS will require more catalyst to see for it to go to double digits.

    Too many players are playing with hype, without more catalyst ATRS may have substantial pullback.

    I too hope they release more news on ATRS so we can get a better idea and hopefully it goes to double digits :)

    Good luck.
    Jul 11 04:14 AM | 1 Like Like |Link to Comment
  • AMD Is Probably Punished Too Much By Investors [View article]
    I think it has little more downside to go. I will definately looking into it closely if it gets to lower $4 range.

    Only thing that concerns me is last few years AMD has been performing really bad in the market. They have lost many percentage chip markets back to INTC and haven't came out with any good products like back in early 2000.

    On top of that ARMS have joined the boat as well.

    AMD has work cut out for them but if it goes any lower, myself will start positioning as well as i believe if it falls or perform any better there could be potential buyout.

    Good luck
    Jul 11 04:14 AM | Likes Like |Link to Comment
  • Why Getting Under The Skin May Enhance Antares' Near-Term Revenue Stream [View article]
    thanks for the info. i have invested some in ATRS as well.. But there are few concerns. for it to go to $10-15 or even higher than that as many seekingalpha reviewers says, it can't just rely on that "intradermal" injector patent. Some drugs simply cannot be administered intradermal because it would not work! Some medications will have to be given either IM or SC hence intradermal injector will be not be utilized as much as you think.
    You are correct in that many drug companies are trying to see if vaccines/etc can be given in intradermal injector recently. Reason? It is less aggressive and less painful. For example, now there are Flu Vaccines that are given as intradermal injection. (needle is less than 5mm long! which is great!)
    However, would this patent make ATRS next multibagger?
    I don't think so.... Only way this will go any higher (>$10) is some other catalyst (ie. other drugs in the pipeline, FDA approval or etc) besides "intradermal patent" will have to come about before it really becomes next multibagger
    Jul 10 10:55 PM | 1 Like Like |Link to Comment